Search for magnetic monopoles in sqrt[s]=7 TeV pp collisions with the ATLAS detector

Search for Highly Ionizing Particles in pp Collisions during LHC Run 2 Using the Full MoEDAL Detector

This search for magnetic monopoles (MMs) and high electric charge objects (HECOs) with spins 0, 1/2, and 1, uses for the first time the full MoEDAL detector, exposed to 6.46  fb^{-1} proton-proton collisions at 13 TeV. The results are interpreted in terms of Drell-Yan and photon-fusion pair production. Mass limits on direct production of MMs of up to 10 Dirac magnetic charges and HECOs with electric charge in the range 10e to 400e, were achieved. The charge limits placed on MM and HECO production are currently the strongest in the world. MoEDAL is the only LHC experiment capable of being directly calibrated for highly ionizing particles using heavy ions and with a detector system dedicated to definitively measuring magnetic charge.

Search for Magnetic Monopole Pair Production in Ultraperipheral Pb+Pb Collisions at sqrt[s_{NN}]=5.36 TeV with the ATLAS Detector at the LHC

This Letter presents a search for highly ionizing magnetic monopoles in 262  μb^{-1} of ultraperipheral Pb+Pb collision data at sqrt[s_{NN}]=5.36  TeV collected by the ATLAS detector at the LHC. A new methodology that exploits the properties of clusters of hits reconstructed in the innermost silicon detector layers is introduced to study highly ionizing particles in heavy-ion data. No significant excess above the background, which is estimated using a data-driven technique, is observed. Using a nonperturbative semiclassical model, upper limits at 95% confidence level are set on the cross section for pair production of monopoles with a single Dirac magnetic charge in the mass range of 20-150 GeV. Depending on the model, monopoles with a single Dirac magnetic charge and mass below 80-120 GeV are excluded.

Performance Outcomes and Return to Sport Following Metacarpal Fractures in Major League Baseball Players

BACKGROUND

Major League Baseball (MLB) players are at risk for metacarpal fractures; however, little is known regarding the impact of these injuries on future performance. The purpose of this study was to determine whether MLB players who sustain metacarpal fractures demonstrate decreased performance on return to competition in comparison to the performance of control-matched peers.

METHODS

Data for MLB position players with metacarpal fractures incurred over 17 seasons were obtained from injury reports, press releases, and player profiles. Age, position, career experience, body mass index (BMI), injury mechanism, handedness, and treatment were recorded. Individual season statistics for the 2 seasons immediately before injury and the 2 seasons after injury were obtained. Controls matched by player position, age, BMI, career experience, and performance statistics were identified. A performance comparison of the cohorts was performed.

RESULTS

Overall, 24 players met inclusion criteria. Eleven players with metacarpal fractures were treated with surgery (46%) and 13 (54%) were treated nonoperatively. Players treated nonoperatively missed significantly fewer games following injury compared with those treated operatively (35.5 vs 52.6 games, P = .04). There was no significant difference in postinjury performance when compared with preinjury performance among the fracture cohorts. Players with metacarpal fractures treated nonoperatively had a significant decline in their Wins Above Replacement (WAR) 2 seasons postinjury (1.37 point decline) in comparison to matched controls (0.84 point increase) (P = .02). There was no significant difference in WAR 1 or 2 seasons postinjury for players with metacarpal fractures treated operatively in comparison to the control cohort.

CONCLUSIONS

Major League Baseball players sustaining metacarpal fractures can expect to return to their preinjury performance levels following both nonoperative and operative treatment. However, players treated nonoperatively may witness a decline in their performance compared with peers over the long term. Orthopedic surgeons treating professional athletes with metacarpal fractures should consider these outcomes when counseling their patients and making treatment recommendations.

Needle-based confocal laser endomicroscopy for diagnosis of pancreatic cystic lesions: a meta-analysis

BACKGROUND AND AIM

The role of needle-based confocal laser endomicroscopy (nCLE) in the diagnosis of pancreatic cystic lesions (PCLs) remains controversial. This study aimed to systematically evaluate the diagnostic accuracy and adverse effects of nCLE in the detection of pathological subtypes in patients with PCLs.

MATERIAL AND METHODS

We conducted a comprehensive literature search using MEDLINE, EMBASE, and Cochrane for identifying studies that reported the use of nCLE for PCLs diagnosis (dated prior to 10 October 2020). Studies with a sample size >10 were included. We used the QUADAS-2 criteria for quality evaluation. We first extracted the diagnostic rates and the information on adverse events (AEs) from the studies; then used STATA15.0 to calculate the variables, draw forest plots and summary receiver operating characteristic (SROC) curves; and finally, we completed subgroup analyses to explore the heterogeneity.

RESULTS

Overall, 299 article titles were identified after an initial search, and ten studies with 547 individuals with PCLs were included in the analysis. The pooled sensitivity, specificity, positive likelihood ratio, and pooled negative likelihood ratio of nCLE in detecting gastric disorders were 90%, 96%, 20.4, and 0.11, respectively. The pooled sensitivity and specificity showed a substantial heterogeneity. An ROC curve was constructed with an area under the curve (AUC) of 0.94. The overall AEs rate of pancreatitis was 2.7%.

CONCLUSIONS

We showed that nCLE had a relatively high sensitivity and specificity for diagnosing PCLs with a relatively low rate of AEs occurring. We suggest that nCLE has good diagnostic accuracy for PCLs.

Emerging therapies in the management of Irritable Bowel Syndrome (IBS)

INTRODUCTION

Irritable bowel syndrome (IBS) is a common, symptom-based disorder of chronic abdominal pain and altered bowel habits. The pathogenesis of IBS is multifactorial, leading to the potential for the development of multiple, diverse treatment strategies. This mechanistic heterogeneity also leads to the realization that available therapies are only effective in a subset of IBS suffers. Current US Food and Drug Administration (FDA) approved therapies for IBS with diarrhea (IBS-D) and IBS with constipation (IBS-C) are reviewed. Limited symptom responses and side effect experiences lead to considerable patient dissatisfaction with currently available IBS treatments. Only a small percentage of IBS patients are on prescription therapies underscoring the potential market and need for additional therapeutic options.

AREAS COVERED

: Expanding on currently available therapies, the serotonergic and endogenous opioid receptor systems continue to be a focus of future IBS treatment development. Additional novel emerging therapies include the endogenous cannabinoid system, bile acid secretion and sequestration, and exploit our enhanced understanding of visceral sensory signaling and intestinal secretomotor function.

EXPERT OPINION

While challenges remain for the future development of IBS therapies, the diverse etiologies underlying the disorder present an opportunity for novel therapies. Hence, great potential is anticipated for future IBS treatment options.

Missing He–McKellar–Wilkens geometric quantum phase

We discuss the appearance of a missing geometric quantum phase from the interaction of the permanent electric dipole moment of a neutral particle with the magnetic field produced by a uniform distribution of the magnetic charges inside an infinitely long non-conductor cylinder with an inner radius r a . This geometric quantum phase is associated with the missing magnetic charge per unit length in a region with a cylindrical shape of radius r a and gives rise to an analogue of the He–McKellar–Wilkens geometric quantum phase. By searching for bound state solutions, we show that an Aharonov–Bohm-type effect arises from the influence of the missing geometric quantum phase on the eigenvalues of energy.

Search for magnetic monopoles produced via the Schwinger mechanism

Electrically charged particles can be created by the decay of strong enough electric fields, a phenomenon known as the Schwinger mechanism¹. By electromagnetic duality, a sufficiently strong magnetic field would similarly produce magnetic monopoles, if they exist². Magnetic monopoles are hypothetical fundamental particles that are predicted by several theories beyond the standard model^3-7 but have never been experimentally detected. Searching for the existence of magnetic monopoles via the Schwinger mechanism has not yet been attempted, but it is advantageous, owing to the possibility of calculating its rate through semi-classical techniques without perturbation theory, as well as that the production of the magnetic monopoles should be enhanced by their finite size^8,9 and strong coupling to photons^2,10. Here we present a search for magnetic monopole production by the Schwinger mechanism in Pb-Pb heavy ion collisions at the Large Hadron Collider, producing the strongest known magnetic fields in the current Universe¹¹. It was conducted by the MoEDAL experiment, whose trapping detectors were exposed to 0.235 per nanobarn, or approximately 1.8 × 10⁹, of Pb-Pb collisions with 5.02-teraelectronvolt center-of-mass energy per collision in November 2018. A superconducting quantum interference device (SQUID) magnetometer scanned the trapping detectors of MoEDAL for the presence of magnetic charge, which would induce a persistent current in the SQUID. Magnetic monopoles with integer Dirac charges of 1, 2 and 3 and masses up to 75 gigaelectronvolts per speed of light squared were excluded by the analysis at the 95% confidence level. This provides a lower mass limit for finite-size magnetic monopoles from a collider search and greatly extends previous mass bounds.

The Role of Confocal Endomicroscopy in the Diagnosis and Management of Pancreatic Cysts

Pancreatic cystic lesions are an increasingly common clinical finding. Current diagnostic techniques cannot reliably differentiate patients with high-risk lesions requiring surgical resection from those that can be safely surveyed or discharged. As a result, some patients may undergo unnecessary surgery with associated morbidity while others enter long-term surveillance with associated healthcare costs. Needle-based confocal laser endomicroscopy enables real time microscopic examination of the epithelial lining of a cyst wall at the time of a standard endoscopic ultrasound examination. The procedure is associated with low rates of adverse events, especially when the probe is loaded into the fine-needle aspiration needle before the procedure and examination times are limited. Needle-based confocal laser endomicroscopy has consistently been shown to have better diagnostic accuracy than cytology, which is often paucicellular and non-diagnostic in pancreatic cystic lesions. Studies have shown that diagnostic accuracy in needle-based confocal laser endomicroscopy is 84–95% in mucinous lesions and 39–99% in serous lesions. However, this technology is expensive and its place in diagnostic algorithms remains uncertain. Despite this, health economic analyses in certain health systems have been favourable, largely because of its potential to be able to discharge patients with benign lesions, such as serous cystic neoplasms, from long-term surveillance. Widespread adoption of this technology is unlikely but it has the potential to have an important role in indeterminate pancreatic cystic lesions.

Association of Circulating Tumor Cells with Inflammatory and Biomarkers in the Blood of Patients with Metastatic Castration-Resistant Prostate Cancer

The identification of specific biomarkers that recognize the functional drivers of heterogeneity in prostate cancer (PCa) and personalized treatment remain challenging in systemic medicine. Liquid biopsy allows for the detection and analysis of personalized predictive biomarkers in single blood samples and specifies the current stage of cancer. The aim of our preliminary study was to investigate the association between an elevated circulating tumor cell (CTC) count and the levels of inflammatory factors (IL-6 and IL-8) and biomarkers (DKK-1, PSA, sHER2, and CD44) in patients with metastasized castration-resistant PCa (mCPRC) under chemotherapy and those with localized PCa. Such an association could be used as a component of cancer progression monitoring. We compared the sensitivity and specificity of two CTC isolation platforms. Twenty-eight patients (12 mCRPC and 16 localized PCa patients) were enrolled. Over the study period, the CTC detection rates were 84% with CellCollector® and 73.5% with CellSearch® System in mCPRC patients. The CTC counts determined by the CellSearch® System (CTC_CS) were correlated significantly with the DKK-1, sHER-2, and PSA concentrations in mCRPC patients. The CTC counts captured by CellCollector® demonstrated no significant association with the concentrations of the tested blood-based biomarkers. The CTC_CS count (AUC = 0.9 (95% CI: 0.72-1.0)) and the PSA level (AUC = 0.95 (95% CI: 0.83-1.0)) presented approximately the same sensitivity and specificity for the overall survival of mCRPC patients. For better personalized characterization, further research on CTC phenotyping and their interactions with tumor-associated blood-released factors is needed.

First Search for Dyons with the Full MoEDAL Trapping Detector in 13 TeV pp Collisions

The MoEDAL trapping detector consists of approximately 800 kg of aluminum volumes. It was exposed during run 2 of the LHC program to 6.46  fb^{-1} of 13 TeV proton-proton collisions at the LHCb interaction point. Evidence for dyons (particles with electric and magnetic charge) captured in the trapping detector was sought by passing the aluminum volumes comprising the detector through a superconducting quantum interference device (SQUID) magnetometer. The presence of a trapped dyon would be signaled by a persistent current induced in the SQUID magnetometer. On the basis of a Drell-Yan production model, we exclude dyons with a magnetic charge ranging up to five Dirac charges (5g_{D}) and an electric charge up to 200 times the fundamental electric charge for mass limits in the range 870-3120 GeV and also monopoles with magnetic charge up to and including 5g_{D} with mass limits in the range 870-2040 GeV.

Serum Biomarkers for the Diagnosis of Glaucoma

Despite the importance of the early detection of glaucoma, most patients with progressive glaucoma show minimal symptoms. We aimed to evaluate biomarkers for glaucoma diagnosis in Korea. Forty-two volunteers with/without open-angle glaucoma were enrolled from January through October 2015—divided into a control or open-angle glaucoma group, which was further divided into normal-tension glaucoma (NTG) and high-tension glaucoma (HTG) groups—and underwent assessments for myelin basic protein (MBP), heat shock protein 60, anti-Sjögren’s-syndrome-related antigen A (SSA) and antigen B (SSB), anti-α-fodrin, and anti-nucleic acid. The glaucoma group showed a higher serum MBP level and lower serum anti-α-fodrin antibody level than the control group (p < 0.05). The NTG group showed higher serum anti-SSA and anti-SSB levels and lower anti-α-fodrin IgG/IgA levels than the HTG group. In the receiver operating characteristic curve analysis, the area under the curve (AUC) for serum MBP level was 0.917 in discriminating between controls and patients with glaucoma. Between the NTG and HTG groups, anti-SSA, anti-SSB, and anti-α-fodrin IgG/IgA levels showed an AUC above 0.8. Thus, these biomarkers were useful for diagnosing glaucoma and discriminating between controls and patients with glaucoma, and patients with NTG and HTG.

Non-invasive assessment of coronary endothelial function in children and adolescents with type 1 diabetes mellitus using isometric handgrip exercise-MRI: A feasibility study

Background

Type 1 diabetes mellitus (T1DM) in children and adolescents is associated with significant cardiovascular morbidity and mortality. Early detection of vascular dysfunction is key to patient management yet current assessment techniques are invasive and not suitable for pediatric patient populations. A novel approach using isometric handgrip exercise during magnetic resonance imaging (IHE-MRI) has recently been developed to evaluate coronary endothelial function non-invasively in adults. This project aimed to assess endothelium-dependent coronary arterial response to IHE-MRI in children with T1DM and in age matched healthy controls.

Materials and methods

Healthy volunteers and children with T1DM (>5 years) were recruited. IHE-MRI cross-sectional coronary artery area measurements were recorded at rest and under stress. Carotid intima media thickness (CIMT) and aortic pulse wave velocity (PWV) were assessed for comparison. Student’s t-tests were used to compare results between groups.

Results and discussion

Seven children with T1DM (3 female, median 14.8 years, mean 14.8 ± 1.9 years) and 16 healthy controls (7 female, median 14.8 years, mean 14.2 ± 2.4 years) participated. A significant increase in stress-induced cross-sectional coronary area was measured in controls (5.4 mm² at rest to 6.39 mm² under stress, 18.8 ± 10.7%, p = 0.0004). In contrast, mean area change in patients with T1DM was not significant (7.17 mm² at rest to 7.59 mm² under stress, 10.5% ± 28.1%, p = n.s.). There was no significant difference in the results for neither PWV nor CIMT between patients and controls, (5.3±1.5 m/s vs.4.8±0.7 m/s and 0.4±0.03mm vs.0.46 mm ± 0.03 respectively, both p = n.s.).

Conclusions

Our pilot study demonstrates the feasibility of using a totally non-invasive IHE-MRI technique in children and adolescents with and without T1DM. Preliminary results suggest a blunted endothelium-dependent coronary vasomotor function in children with T1DM (>5 years). Better knowledge and new methodologies may improve surveillance and care for T1DM patients to reduce cardiovascular morbidity and mortality.

Search for Magnetic Monopoles and Stable High-Electric-Charge Objects in 13 Tev Proton-Proton Collisions with the ATLAS Detector

A search for magnetic monopoles and high-electric-charge objects is presented using 34.4  fb^{-1} of 13 TeV pp collision data collected by the ATLAS detector at the LHC during 2015 and 2016. The considered signature is based upon high ionization in the transition radiation tracker of the inner detector associated with a pencil-shape energy deposit in the electromagnetic calorimeter. The data were collected by a dedicated trigger based on the tracker high-threshold hit capability. The results are interpreted in models of Drell-Yan pair production of stable particles with two spin hypotheses (0 and 1/2) and masses ranging from 200 to 4000 GeV. The search improves by approximately a factor of 5 the constraints on the direct production of magnetic monopoles carrying one or two Dirac magnetic charges and stable objects with electric charge in the range 20≤|z|≤60 and extends the charge range to 60<|z|≤100.

A prospective trial of CONfocal endomicroscopy in CYSTic lesions of the pancreas: CONCYST-01

Background and study aims  Pancreatic cystic lesions (PCL) are common. While some harbor malignant potential, accurate preoperative diagnosis remains challenging. Needle-based confocal laser endomicroscopy (nCLE) via a 19G FNA needle enables real-time imaging of the cyst wall. This study evaluated the safety and utility of nCLE in patients with an indeterminate PCL undergoing EUS-FNA. Patients and methods  The CONCYST study prospectively recruited patients with indeterminate PCL attending three hepatopancreaticobiliary (HPB) referral centers in the UK, with indeterminate PCL, who required EUS-FNA between July 2014 and October 2016. Following the procedure, all patients were followed up in telephone clinic for at least 12 months. Ethical approval for the study was granted by the National Research Ethics Service (14/LO/0040). Results  Sixty-seven patient were recruited, 11 excluded and 56 included in the final analysis: 35 male, 21 female; median age 68 (range 28 - 80). Recognizable confocal images were obtained in 48 of 56 cases. Median nCLE scanning time was 5 minutes and did not exceed 10 minutes in any case. EUS-nCLE findings correlated with final diagnosis (based on imaging, cytology and multidisciplinary team review) in 43/56 (77 %) of cases, compared with 37/56 (66 %) for cytology alone ( P  = 0.12). One patient experienced mild pruritus following the procedure and another developed an infected pseudocyst, which resolved with antibiotics. Conclusions  EUS-nCLE under conscious sedation in the day case setting is safe and provides additional information to standard EUS-FNA for diagnosing indeterminate PCL.

Magnetic Monopole Search with the Full MoEDAL Trapping Detector in 13 TeV pp Collisions Interpreted in Photon-Fusion and Drell-Yan Production

MoEDAL is designed to identify new physics in the form of stable or pseudostable highly ionizing particles produced in high-energy Large Hadron Collider (LHC) collisions. Here we update our previous search for magnetic monopoles in Run 2 using the full trapping detector with almost four times more material and almost twice more integrated luminosity. For the first time at the LHC, the data were interpreted in terms of photon-fusion monopole direct production in addition to the Drell-Yan-like mechanism. The MoEDAL trapping detector, consisting of 794 kg of aluminum samples installed in the forward and lateral regions, was exposed to 4.0  fb^{-1} of 13 TeV proton-proton collisions at the LHCb interaction point and analyzed by searching for induced persistent currents after passage through a superconducting magnetometer. Magnetic charges equal to or above the Dirac charge are excluded in all samples. Monopole spins 0, ½, and 1 are considered and both velocity-independent and-dependent couplings are assumed. This search provides the best current laboratory constraints for monopoles with magnetic charges ranging from two to five times the Dirac charge.

A Barter Economy in Tumors: Exchanging Metabolites through Gap Junctions

To produce physiological functions, many tissues require their cells to be connected by gap junctions. Such diffusive coupling is important in establishing a cytoplasmic syncytium through which cells can exchange signals, substrates and metabolites. Often the benefits of connectivity become apparent solely at the multicellular level, leading to the notion that cells work for a common good rather than exclusively in their self-interest. In some tumors, gap junctional connectivity between cancer cells is reduced or absent, but there are notable cases where it persists or re-emerges in late-stage disease. Diffusive coupling will blur certain phenotypic differences between cells, which may seem to go against the establishment of population heterogeneity, a central pillar of cancer that stems from genetic instability. Here, building on our previous measurements of gap junctional coupling between cancer cells, we use a computational model to simulate the role of connexin-assembled channels in exchanging lactate and bicarbonate ions down their diffusion gradients. Based on the results of these simulations, we propose that an overriding benefit of gap junctional connectivity may relate to lactate/bicarbonate exchange, which would support an elevated metabolic rate in hypoxic tumors. In this example of barter, hypoxic cancer cells provide normoxic neighbors with lactate for mitochondrial oxidation; in exchange, bicarbonate ions, which are more plentiful in normoxic cells, are supplied to hypoxic neighbors to neutralize the H⁺ ions co-produced glycolytically. Both cells benefit, and so does the tumor.

Monopole production via photon fusion and Drell-Yan processes: MadGraph implementation and perturbativity via velocity-dependent coupling and magnetic moment as novel features

In this work we consider point-like monopole production via photon-fusion and Drell-Yan processes in the framework of an effective U(1) gauge field theory obtained from conventional models describing the interaction of spin  magnetically-charged fields with ordinary photons, upon electric-magnetic dualisation. We present arguments based on such dualities which support the conjecture of an effective monopole-velocity-dependent magnetic charge. For the cases of spin- and spin-1 monopoles, we also include a magnetic-moment term κ , which is treated as a new phenomenological parameter and, together with the velocity-dependent coupling, allows for a perturbative treatment of the cross-section calculation. We discuss unitarity issues within these effective field theories, in particular we point out that in the spin-1 monopole case only the value κ = 1 may restore unitarity. However from an effective-field-theory point of view, this lack of unitarity should not be viewed as an impediment for the phenomenological studies and experimental searches of generic spin-1 monopoles, given that the potential appearance of new degrees of freedom in the ultraviolet completion of such models might restore it. The second part of the paper deals with an appropriate implementation of photon-fusion and Drell-Yan processes based on the above theoretical scenarios into MadGraph UFO models, aimed to serve as a useful tool in interpretations of monopole searches at colliders such as LHC, especially for photon fusion, given that it has not been considered by experimental collaborations so far. Moreover, the experimental implications of such perturbatively reliable monopole searches have been laid out.

Ions, Protons, and Photons as Signatures of Monopoles

Magnetic monopoles have been a subject of interest since Dirac established the relationship between the existence of monopoles and charge quantization. The Dirac quantization condition bestows the monopole with a huge magnetic charge. The aim of this study was to determine whether this huge magnetic charge allows monopoles to be detected by the scattering of charged ions and protons on matter where they might be bound. We also analyze if this charge favors monopolium (monopole–antimonopole) annihilation into many photons over two photon decays.

Singular lensing from the scattering on special space-time defects

It is well known that certain special classes of self-gravitating point-like defects, such as global (non gauged) monopoles, give rise to non-asymptotically flat space-times characterized by solid angle deficits, whose size depends on the details of the underlying microscopic models. The scattering of electrically neutral particles on such space-times is described by amplitudes that exhibit resonant behaviour when thescattering and deficit angles coincide. This, in turn, leads to ring-like structures where the cross sections are formally divergent ("singular lensing"). In this work, we revisit this particular phenomenon, with the twofold purpose of placing it in a contemporary and more general context, in view of renewed interest in the theory and general phenomenology of such defects, and, more importantly, of addressing certain subtleties that appear in the particular computation that leads to the aforementioned effect. In particular, by adopting a specific regularization procedure for the formally infinite Legendre series encountered, we manage to ensure the recovery of the Minkowski space-time, and thus the disappearance of the lensing phenomenon, in the no-defect limit, and the validity of the optical theorem for the elastic total cross section. In addition, the singular nature of the phenomenon is confirmed by means of an alternative calculation, which, unlike the original approach, makes no use of the generating function of the Legendre polynomials, but rather exploits the asymptotic properties of the Fresnel integrals.

Search for magnetic monopoles with the MoEDAL forward trapping detector in 13 TeV proton-proton collisions at the LHC

The MoEDAL experiment addresses a decades-old issue, the search for an elementary magnetic monopole, first theorised in 1931 by Dirac to explain electric charge quantisation. Since then it was showed that magnetic monopoles occur naturally in grand unified theories as solutions of classical equations of motion. The dedicated experiment can enjoy a new energy regime opened at the LHC allowing direct probes of magnetic monopoles at the TeV scale for the first time. MoEDAL pioneered a technique in which monopoles would be slowed down in a dedicated aluminium array and the presence of trapped monopoles is probed by analysing the samples with a superconducting magnetometer. The MoEDAL forward trapping detector array deployed in 2015 was analysed and found consistent with zero trapped magnetic charge, allowing to set the first LHC constraints for monopoles carrying twice or thrice the Dirac charge.

Searches for magnetic monopoles and beyond with MoEDAL at the LHC

The MoEDAL experiment at the LHC is optimised to detect highly-ionising particles such as magnetic monopoles, dyons and (multiply) electrically-charged stable massive particles predicted in a number of theoretical scenarios. MoEDAL, deployed in the LHCb cavern, combines passive nuclear track detectors with magnetic monopole trapping volumes, while cavern backgrounds are being monitored with an array of MediPix detectors. The detector concept and its physics reach is presented with emphasis given to recent results on monopole searches providing the best limits on high magnetic charges in colliders. The potential to search for heavy, long-lived supersymmetric electrically-charged particles and multi-charged states is also discussed.

Light-by-Light Scattering Constraint on Born-Infeld Theory

The recent measurement by ATLAS of light-by-light scattering in LHC Pb-Pb collisions is the first direct evidence for this basic process. We find that it excludes a range of the mass scale of a nonlinear Born-Infeld extension of QED that is ≲100  GeV, a much stronger constraint than those derived previously. In the case of a Born-Infeld extension of the standard model in which the U(1)_{Y} hypercharge gauge symmetry is realized nonlinearly, the limit on the corresponding mass reach is ∼90  GeV, which, in turn, imposes a lower limit of ≳11  TeV on the magnetic monopole mass in such a U(1)_{Y} Born-Infeld theory.

Search for Magnetic Monopoles with the MoEDAL Forward Trapping Detector in 13 TeV Proton-Proton Collisions at the LHC

MoEDAL is designed to identify new physics in the form of long-lived highly ionizing particles produced in high-energy LHC collisions. Its arrays of plastic nuclear-track detectors and aluminium trapping volumes provide two independent passive detection techniques. We present here the results of a first search for magnetic monopole production in 13 TeV proton-proton collisions using the trapping technique, extending a previous publication with 8 TeV data during LHC Run 1. A total of 222 kg of MoEDAL trapping detector samples was exposed in the forward region and analyzed by searching for induced persistent currents after passage through a superconducting magnetometer. Magnetic charges exceeding half the Dirac charge are excluded in all samples and limits are placed for the first time on the production of magnetic monopoles in 13 TeV pp collisions. The search probes mass ranges previously inaccessible to collider experiments for up to five times the Dirac charge.

A proteomic signature of ovarian cancer tumor fluid identified by highthroughput and verified by targeted proteomics

Tumor fluid samples have emerged as a rich source for the identification of ovarian cancer in the context of proteomics studies. To uncover differences among benign and malignant ovarian samples, we performed a quantitative proteomic study consisting of albumin immunodepletion, isotope labeling with acrylamide and in-depth proteomic profiling by LC-MS/MS in a pool of 10 samples of each histological type. 1135 proteins were identified, corresponding to 505 gene products. 223 proteins presented associated quantification and the comparative analysis of histological types revealed 75 differentially abundant proteins. Based on this, we developed a panel for targeted proteomic analysis using the multiple reaction monitoring (MRM) method for validation of 51 proteins in individual samples of high-grade serous ovarian tumor fluids (malignant) and benign serous cystadenoma tumor fluids. This analysis showed concordant results in terms of average amounts of proteins, and APOE, SERPINF2, SERPING1, ADAM17, CD44 and OVGP1 were statistically significant between benign and malignant group. The results observed in the MRM for APOE were confirmed by western blotting, where APOE was more abundant in malignant samples. This molecular signature can contribute to improve tumor stratification and shall be investigated in combination with current biomarkers in larger cohorts to improve ovarian cancer diagnosis.

BIOLOGICAL SIGNIFICANCE

Despite advances in cancer research, ovarian cancer has a high mortality and remains a major challenge due to a number of particularities of the disease, especially late diagnosis caused by vague clinical symptoms, the cellular and molecular heterogeneity of tumors, and the lack of effective treatment. Thus, efforts are directed to better understand this neoplasia, its origin, development and, particularly the identification and validation of biomarkers for early detection of the disease in asymptomatic stage. In the present work, we confirmed by MRM method in individual ovarian tumor fluid samples the regulation of 27 proteins out of 33 identified in a highthroughput study. We speculate that the presence and/or differential abundance observed in tumor fluid is a cooperation primarily of high rates of secretion of such tumor proteins to extra tumor environment that will at the end accumulate in plasma, and also the accumulation of acute-phase proteins throughout the entire body. On top of that, consideration of physiological influences in the interpretation of expression observed, including age, menopause status, route-of-elimination kinetics and metabolism of the tumor marker, coexisting disease, hormonal imbalances, life-style influences (smoking, alcoholism, obesity), among others, are mandatory to enable the selection of good protein tumor marker candidates for extensive validation.

Search for magnetic monopoles in polar volcanic rocks

For a broad range of values of magnetic monopole mass and charge, the abundance of monopoles trapped inside Earth would be expected to be enhanced in the mantle beneath the geomagnetic poles. A search for magnetic monopoles was conducted using the signature of an induced persistent current following the passage of igneous rock samples through a SQUID-based magnetometer. A total of 24.6 kg of rocks from various selected sites, among which 23.4 kg are mantle-derived rocks from the Arctic and Antarctic areas, was analyzed. No monopoles were found, and a 90% confidence level upper limit of 9.8 × 10(-5)/g is set on the monopole density in the search samples.